Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.080
-0.020 (-1.82%)
Sep 18, 2024, 4:00 PM EDT - Market closed

Adial Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
-12.24-5.12-12.73-19.42-10.89-8.59
Upgrade
Depreciation & Amortization
0000.0600
Upgrade
Asset Writedown & Restructuring Costs
---1.55--
Upgrade
Loss (Gain) on Equity Investments
0.610.19----
Upgrade
Stock-Based Compensation
0.981.753.374.242.011.6
Upgrade
Other Operating Activities
4.52-1.831.940.17-0.44
Upgrade
Change in Accounts Payable
0.2-0.160.02-0.350.620.09
Upgrade
Change in Other Net Operating Assets
-0.43-0.63-1.191.820.620.12
Upgrade
Operating Cash Flow
-6.39-6.81-11.19-11.95-7.63-6.34
Upgrade
Capital Expenditures
----0.06--
Upgrade
Sale of Property, Plant & Equipment
0.71.5----
Upgrade
Cash Acquisitions
---0.03--
Upgrade
Other Investing Activities
-----0.35-
Upgrade
Investing Cash Flow
0.71.5--0.03-0.35-
Upgrade
Issuance of Common Stock
4.380.759.1313.646.1710.3
Upgrade
Repurchase of Common Stock
-0-0----
Upgrade
Other Financing Activities
3.383.38---0.56-1.05
Upgrade
Financing Cash Flow
7.764.139.1313.645.619.25
Upgrade
Net Cash Flow
2.07-1.17-2.061.66-2.382.91
Upgrade
Free Cash Flow
-6.39-6.81-11.19-12.01-7.63-6.34
Upgrade
Free Cash Flow Per Share
-2.40-4.78-11.17-16.16-15.31-16.08
Upgrade
Levered Free Cash Flow
-2.99-3.21-4.67-5.33-3.57-3.34
Upgrade
Unlevered Free Cash Flow
-2.99-3.21-4.67-5.33-3.57-3.34
Upgrade
Change in Net Working Capital
-0.50.731.26-1.5-1.13-0.21
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.